Two-phase optical assay

• US 5,674,699 A
• Filed: 12/22/1994
• Issued: 10/07/1997
• Est. Priority Date: 06/08/1993
• Status: Expired due to Term

• Current Assignee: Chronomed Incorporated
• Original Assignee: Chronomed Incorporated
• Inventors: Saunders, Alexander, Zarowitz, Michael Allan
• Primary Examiner(s): Hutzell, Paula K.
• Assistant Examiner(s): GRUN, JAMES LESLIE
• Application Number:
  US08/361,832
• Time in Patent Office: 1,020 Days
• Field of Search: 435/7.4, 435/7.8, 435/7.93, 435/7.94, 435/7.1, 436/67, 436/501, 436/518, 436/528, 436/529, 436/531, 436/532, 436/533, 436/534, 436/172, 436/805
• US Class Current: 435/7.93
• CPC Class Codes: G01N 33/54313 the carrier being characterised by its particulate form
• CPC Class Codes: G01N 33/582 with fluorescent label
• CPC Class Codes: G01N 33/721 Haemoglobin
• CPC Class Codes: G01N 33/723 Glycosylated haemoglobin

Abstract

A method is provided for measuring an analyte in a sample comprising adding substantially transparent particles to a sample in solution or suspension, said particles having an affinity for said analyte; fractionating the particles from the solution or suspension to form a particle-rich fraction and a substantially particle-free fraction; optically reading the particle-rich fraction at a first and a second wavelength; optically reading the substantially particle-free fraction at at least the first wavelength; and correlating the readings through the particle-rich fraction and the substantially particle-free fraction of the sample, with similar measurements in a particle-containing "blank" to obtain a quantitative determination of the analyte originally present in the sample.

Claims

1. A method for measuring one or more analytes in a sample comprising

adding substantially transparent particles to a sample solution;

incubating the particles and an affinity reagent with the sample to form a mixture;

fractionating the mixture to form a particle-rich fraction and a substantially particle-free fraction in fluid contact within a single container, the analyte being partitioned, as a result of binding to said affinity reagent, to concentrate it in one of said fractions;

optically reading the particle-rich fraction in said container at an analyte-detecting wavelength and a control wavelength;

optically reading the substantially particle-free fraction in said container at said analyte-detecting and said control wavelength;

said particle rich and particle free fractions being still in fluid contact in said container at the time of said readings;

correlating the readings through the particle-rich fraction and the substantially particle-free fraction of the sample with similar readings through a "blank" containing similar particles in a buffer solution, to obtain a quantitative determination of at least one analyte originally present in the sample, said correlating correcting the determination for the optical properties of the particle after absorption of analyte and the optical properties of unbound constituents of the sample which are present in the free volume of the particle-free fraction.

2. The method according to claim 1 wherein the particles are attached to the affinity reagent.

3. The method according to claim 2 wherein the affinity reagent is selected from the group consisting of carbohydrates, lectins, antibodies, antigens, enzymes, enzyme substrates, and enzyme inhibitors.

4. The method according to claim 1 wherein said particles are selected from the group consisting of dextran, agarose, agar, deacetlytated chitin, and starch.

5. The method according to claim 1 wherein one analyte is glycosylated hemoglobin.

6. The method according to claim 5 wherein a second analyte is unglycosylated hemoglobin.

7. The method according to claim 5 wherein said mixture is fractionated by centrifugation.

8. The method according to claim 1 wherein said fractionation is effected by permitting the particles to settle under the influence of gravity.

9. The method according to claim 1 wherein said fractionation is effected by collecting said particles on a frit.

10. The method of claim 1 in which an analyte analogue is also incubated with the sample, and the analyte analogue competes with the analyte for binding to the affinity reagent.

11. The method of claim 10 in which the analyte analogue is optically detectable, either intrinsically or as a result of conjugation to an optically detectable label, and the affinity reagent is conjugated to the particles.

12. The method of claim 10 in which the affinity reagent is optically detectable, either intrinsically or as a result of conjugation to an optically detectable label, and the analyte analogue is conjugated to the particles.

13. The method of claim 1 in which the particles are porous particles having pores of predetermined pore size, the affinity reagent is soluble and optically detectable, either intrinsically or by virtue of a label, the affinity reagent binds to the analyte to form a complex, and the pore size of the particles is chosen so that the affinity reagent can enter the pores but the complex of the affinity reagent and the analyte is substantially excluded from the pores of the particles.

14. The method of claim 6 in which the analyte competes with an analyte analogue which is optically detectable, either intrinsically or as a result of conjugation to an optically detectable label, for binding to the affinity reagent.

15. The method of claim 1 wherein the affinity reagent has a boronyl group through which it binds to glycated analytes.

16. The method of claim 1 wherein the particles are carbohydrate particles.

17. The method of claim 1 wherein the particles are plastic particles.

18. The method of claim 17 wherein the particles are polystyrene particles.